Whole genome amplification replicates the entire DNA content of a sample and can thus help to circumvent material limitations when insufficient DNA is available for planned genetic analyses. However, there are conflicting data in the literature whether whole genome amplification introduces bias or reflects precisely the spectrum of starting DNA. We analyzed the origins of discrepancies in KRAS (Kirsten rat sarcoma viral oncogene homolog gene) mutation detection in six of ten samples amplified using the GenomePlex® Tissue Whole Genome Amplification kit 5 (WGA5; Sigma-Aldrich, St. Louis, MO, USA) and KRAS StripAssay® (KRAS SA; ViennaLab Diagnostics, Vienna, Austria). We undertook reextraction, reamplification, retyping, authentication, reanalysis, and reinterpretation to determine whether the discrepancies originated during the preanalytical, analytical, and/or interpretative phase of genotyping. We conclude that a combination of glass slide/sample heterogeneity and biased amplification due to stochastic effects in the early phases of whole genome amplification (WGA) may have adversely affected the results obtained. Our findings are relevant for both forensic genetics testing and massively parallel sequencing using preamplification.

Institute of Molecular and Translational Medicine Faculty of Medicine and Dentistry Palacky University Olomouc Olomouc Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc16000320

003      

CZ-PrNML

005      

20190704103309.0

007      

ta

008      

160108s2015 gw f 000 0|eng||

009      

AR

024    7_

$a 10.1002/elps.201400136 $2 doi

035    __

$a (PubMed)25655305

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a gw

100    1_

$a Stránská, Jana $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic. $7 xx0143285

245    10

$a Whole genome amplification induced bias in the detection of KRAS-mutated cell populations during colorectal carcinoma tissue testing / $c J. Stranska, S. Jancik, R. Slavkovsky, V. Holinkova, M. Rabcanova, P. Vojta, M. Hajduch, J. Drabek,

520    9_

$a Whole genome amplification replicates the entire DNA content of a sample and can thus help to circumvent material limitations when insufficient DNA is available for planned genetic analyses. However, there are conflicting data in the literature whether whole genome amplification introduces bias or reflects precisely the spectrum of starting DNA. We analyzed the origins of discrepancies in KRAS (Kirsten rat sarcoma viral oncogene homolog gene) mutation detection in six of ten samples amplified using the GenomePlex® Tissue Whole Genome Amplification kit 5 (WGA5; Sigma-Aldrich, St. Louis, MO, USA) and KRAS StripAssay® (KRAS SA; ViennaLab Diagnostics, Vienna, Austria). We undertook reextraction, reamplification, retyping, authentication, reanalysis, and reinterpretation to determine whether the discrepancies originated during the preanalytical, analytical, and/or interpretative phase of genotyping. We conclude that a combination of glass slide/sample heterogeneity and biased amplification due to stochastic effects in the early phases of whole genome amplification (WGA) may have adversely affected the results obtained. Our findings are relevant for both forensic genetics testing and massively parallel sequencing using preamplification.

650    _2

$a kolorektální nádory $x genetika $7 D015179

650    _2

$a geny ras $x genetika $7 D011905

650    _2

$a genom lidský $x genetika $7 D015894

650    _2

$a genomika $x metody $7 D023281

650    _2

$a genotypizační techniky $x metody $7 D060005

650    _2

$a lidé $7 D006801

650    _2

$a techniky amplifikace nukleových kyselin $x metody $7 D021141

650    _2

$a sekvenční analýza DNA $7 D017422

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Jančík, Sylwia $7 xx0098451

700    1_

$a Slavkovský, Rastislav $7 xx0096675

700    1_

$a Holinková, Veronika $7 xx0128558

700    1_

$a Rabčanová, Miroslava, $d 1954- $7 xx0128432

700    1_

$a Vojta, Petr $7 xx0169437

700    1_

$a Hajdúch, Marián, $d 1969- $7 xx0050218

700    1_

$a Drábek, Jiří, $d 1969- $7 xx0067364

773    0_

$w MED00001508 $t Electrophoresis $x 1522-2683 $g Roč. 36, č. 6 (2015), s. 937-940

856    41

$u https://pubmed.ncbi.nlm.nih.gov/25655305 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20160108 $b ABA008

991    __

$a 20190704103501 $b ABA008

999    __

$a ok $b bmc $g 1102601 $s 924526

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2015 $b 36 $c 6 $d 937-940 $e 20150219 $i 1522-2683 $m Electrophoresis $n Electrophoresis $x MED00001508

GRA    __

$a NT14282 $p MZ0

LZP    __

$a Pubmed-20160108